TrialThe Journal of infectious diseases2015

Intrahepatic and Peripheral CXCL10 Expression in Hepatitis C Virus-Infected Patients Treated With Telaprevir, Pegylated Interferon, and Ribavirin.

Marija Zeremski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.